Peripherally derived myeloid cells induce disease-dependent phenotypic changes in microglia

Estrid Thougaard1,2, Brianna Carney3, Agnieszka Wlodarczyk1,2

  • 1Neurobiology Research, Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark.

PubMed

Insights

Peripheral myeloid cells influence brain microglia differently based on central nervous system (CNS) injury type and timing. Understanding these interactions is key for developing neuroprotective therapies for conditions like multiple sclerosis and stroke.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Peripherally derived myeloid cells infiltrate the central nervous system (CNS) during injury and disease, contributing to neuroinflammation.
  • The phenotype and function of these infiltrating cells vary with injury type and disease phase, influencing interactions with resident microglia.

Purpose of the Study:

  • To develop an in vitro system for investigating communication between peripheral myeloid cells and microglia.
  • To uncover differences in myeloid cell-microglia crosstalk based on disease model (experimental autoimmune encephalomyelitis [EAE] and cerebral ischemia [pMCAO]) and disease timing.

Main Methods:

  • Isolation of peripheral myeloid cells from EAE and pMCAO mouse models at different time points post-disease onset.
  • Co-culture of isolated peripheral myeloid cells with primary microglia to assess phenotypic and gene expression changes.
  • Analysis of microglial morphology and gene expression related to inflammatory and phagocytic pathways.

Main Results:

  • Peripheral myeloid cells from acute EAE induced microglial morphological changes and increased inflammatory gene expression.
  • Peripheral myeloid cells from chronic pMCAO induced inflammatory and phagocytic gene expression changes in microglia without altering morphology.
  • Identified disease-specific and time-dependent alterations in myeloid cell-microglia interactions.

Conclusions:

  • The impact of infiltrating myeloid cells on microglia is context-dependent, varying by disease model and phase.
  • The developed in vitro assay is a valuable tool for studying myeloid cell interactions in various CNS neuroinflammatory conditions.
  • Findings highlight the importance of considering disease context and timing for myeloid cell-mediated neuroinflammation and potential therapeutic strategies.